Oxytocin
Also known as Pitocin, Syntocinon, OXT, Oxytocin acetate
Oxytocin is a nine amino acid hormone from the pituitary that drives uterine contractions, milk letdown and a range of social behaviors. As an injection it is a hospital drug for childbirth. As a nasal spray it has been studied for autism, social anxiety and sexual function in small trials with mixed, mostly disappointing results.
Reviewed by the amino101 editorial team. .
Quick start
What people commonly do. Not a prescription.- Typical dose
- 10 to 40 IU, most trials used 24 IU
- How often
- once daily or per occasion
- Where
- Intranasal spray, split between nostrils
- Timing
- 30 to 45 minutes before a social or intimate situation
- Effects timeline
- subtle calm or warmth within 30 to 60 minutes if anything is felt at all; many people notice nothing, and the controlled trials mostly found no difference from placebo
- Storage
- fridge 2 to 8 C for spray and powder, protect from light, use a mixed spray within 4 weeks
- Cycle length
- per occasion; trial courses ran 4 to 24 weeks
- Break between
- not defined; daily use beyond a few weeks has only trial data in autism, where it did nothing
A 1000 IU research vial in 10 mL gives 100 IU per mL, so a 0.1 mL spray delivers about 10 IU. Research vials are often labeled in mg; roughly 1 mg is 500 to 600 IU, but the conversion varies by product.
Overview
Oxytocin is a cyclic nonapeptide made in the hypothalamus and released from the posterior pituitary. It was the first peptide hormone ever synthesized, by Vincent du Vigneaud in 1953, and synthetic oxytocin has been a standard obstetric drug for decades. By intravenous or intramuscular injection it is used to start or strengthen labor and to control bleeding after delivery. That use is well established, tightly monitored, and has nothing to do with the way oxytocin is used in the peptide community.
The interest outside obstetrics comes from its role in the brain, where it shapes bonding, trust, social recognition and sexual response. Intranasal oxytocin, which is thought to reach the brain through the nasal passages, has been tested in dozens of small trials for autism, social anxiety, schizophrenia, depression and sexual dysfunction. The results are mixed at best. The largest and best designed trial, in 290 children and adolescents with autism, found no benefit over placebo after 24 weeks. Trials in women and couples with sexual complaints found no meaningful advantage over placebo either, though some reported more intense orgasm. Many early positive findings came from very small studies and have not held up.
Community use is almost entirely intranasal, at 10 to 40 IU per dose, for social ease, intimacy, mood or libido. Vendors sell either premixed sprays or lyophilized powder to be mixed into a spray. The injectable form is a hospital drug for uterine contractions and should stay that way; nobody should inject oxytocin for social or sexual purposes. This page is educational and describes approved uses and research, not a protocol for anyone to follow.
How it works
Oxytocin binds the oxytocin receptor, a G protein coupled receptor found on uterine smooth muscle, breast myoepithelial cells and neurons throughout the brain. In the uterus it raises intracellular calcium and causes rhythmic contractions, which is the basis of its obstetric use. In the breast it contracts the cells around milk ducts to eject milk. In the brain it is released from hypothalamic neurons into regions including the amygdala, nucleus accumbens and prefrontal cortex, where it reduces social threat responses, increases attention to social cues and supports pair bonding and parental behavior. Intranasal delivery is believed to carry some oxytocin along olfactory and trigeminal nerve pathways into the brain, though how much reaches the relevant regions in humans is debated. At higher doses it also activates vasopressin receptors, which contributes to its effects on blood pressure and water retention.
Where the research stands
ObstetricsStrong evidence
- Labor induction and augmentation. Decades of approved use by intravenous infusion under monitoring; this is a hospital drug for this purpose.
- Postpartum hemorrhage. Intramuscular or intravenous oxytocin after delivery is standard care worldwide to reduce bleeding.
Social and developmental conditionsWeak or mixed
- Autism spectrum disorder. The largest randomized trial, 290 participants over 24 weeks, found no benefit over placebo; earlier small positive studies did not hold up.
- Social anxiety. Small trials show modest effects on specific tasks, often as an add on to exposure therapy, with no convincing clinical benefit on its own.
Sexual function and intimacyWeak or mixed
- Libido and arousal. Controlled trials in couples and in women with sexual dysfunction found no advantage over placebo on desire or arousal.
- Orgasm intensity. Some participants in couple studies reported more intense orgasm, a secondary finding that has not been confirmed.
Mood and stressEmerging
- Stress reactivity. Small studies show reduced cortisol and amygdala response to social stress after a dose; clinical relevance is unclear.
- clinical (approved drug)Synthetic oxytocin by intravenous infusion reliably induces and augments labor and reduces postpartum bleeding, the basis of decades of approved obstetric use.
- human RCTA 24 week randomized trial of intranasal oxytocin in 290 children and adolescents with autism found no improvement in social function compared with placebo.
- human RCTIn a placebo controlled crossover study, intranasal oxytocin given before intercourse in healthy couples produced no significant change in sexual function scores, with some reports of more intense orgasm.
- human RCTA single intranasal dose increased trust in an economic game in healthy men in an early study, a finding that later and larger studies have struggled to replicate.
- human pilotIntranasal oxytocin reduced amygdala activation to fearful faces in small imaging studies, supporting a role in dampening social threat response.
- rodentIn rodents, oxytocin receptor signaling in reward and social regions is required for pair bonding and maternal behavior.
Rodent and in vitro mean no human data for that finding. Human pilot means small, often uncontrolled. Human RCT means randomized and controlled. Clinical means an approved drug with regulatory data.
Levels over time
Modeled from the half-life. Illustrative, not measured.A half-life of 5 min against dosing every 24 h means each dose has cleared before the next. Nothing stacks; you start from zero every time, and the tissue effect is what carries over.
The plasma half-life is almost irrelevant to nasal use. What matters is how much crosses into the brain and how long receptor effects persist there, and both are poorly measured in humans. This is why trials dose 30 to 45 minutes before whatever they are testing.
Oxytocin dosage and protocols
Oxytocin is not cycled in the usual sense. Community use is per occasion, a nasal dose before a social event or intimacy. Trial courses ran daily for 4 to 24 weeks without a taper, and the long autism trial found no benefit and no major safety problem with that schedule. There is no evidence that tolerance develops with intermittent use, and no evidence that regular daily use does anything useful in healthy adults.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Social ease or intimacy, community | 20 to 24 IU | once, 30 to 45 minutes before the occasion | Intranasal, split between nostrils |
| Lower end or first try | 10 IU | once before the occasion | Intranasal |
| Daily course, as in research | 24 IU | once or twice daily for 4 to 8 weeks | Intranasal |
| Obstetric use, approved | set by hospital protocol in milliunits per minute | continuous infusion during labor, or 10 IU once after delivery | Intravenous or intramuscular, clinical setting only |
Research trials dose 30 to 45 minutes before the task being measured, so community use copies that: a spray before a date, a difficult conversation or intimacy. Food does not matter. A mixed spray loses potency at room temperature within days, so it is kept refrigerated and brought out just before use. Some people report that the effect is subtle enough that expectation does most of the work, which matches the placebo response seen in trials.
Research trials of intranasal oxytocin mostly used 24 IU per dose, with some using 16 to 40 IU. Community use reports 10 to 40 IU per dose intranasally. Injectable dosing is set by hospital protocol in milliunits per minute and has no place outside clinical care.
Dose calculator
U-100 insulin syringeUnits are a volume on the syringe, not an amount of peptide. Concentration changes every time you change the water volume. The standalone calculator explains the math.
| Vial | Suggested water | Concentration | Low dose draw |
|---|---|---|---|
| 1000 IU | 10 mL | 100 IU/mL | 10 units |
| 500 IU | 5 mL | 100 IU/mL | 10 units |
How to reconstitute Oxytocin
- 1
Wash your hands and wipe the work surface. Swab both vial stoppers with alcohol and let them dry.
- 2
Pick the water volume with the calculator above and write it on the vial. The concentration means nothing without it.
- 3
Draw the bacteriostatic water into a mixing syringe.
- 4
Insert at an angle and let the water run down the inside wall. Never squirt it straight onto the powder.
- 5
Swirl gently or leave it to dissolve. Do not shake.
- 6
Label with the date and water volume. Store in the fridge at 2 to 8 C and use within about 4 weeks.
- 7
Unmixed vials keep for months in the fridge and longer in the freezer, sealed and out of light.
- Full walkthrough with syringe reading and site rotation: reconstitution guide.
- ✓White, fluffy cake
Lyophilized powder should look like a small white puck or fluffy cake at the bottom of the vial. That is a proper freeze-dry.
- ✓Clear after mixing
Once dissolved the solution should be water-clear with nothing floating in it.
- !Slight clumping
Small clumps that dissolve with gentle swirling are fine. Shipping compacts powder.
- ✕Collapsed or melted
Powder stuck to the sides, glassy, or shrunken means it got hot in transit. Contact the vendor.
- ✕Cloudy or particles
Persistent cloudiness or visible particles after mixing means degraded or contaminated product. Do not use it.
- First 30 to 90 minutes after a nasal dose
Possibly a mild sense of calm, warmth or openness; many people feel nothing, and some feel slightly flushed or get a mild headache.
- First 1 to 2 weeks of daily use
No cumulative effect has been shown in healthy adults; whatever is noticed per dose is what there is.
- Week 4 to 24
This is the window the autism and anxiety trials measured, and most found no difference from placebo; if a daily course has not done anything by a month, longer will not either.
Interactions and stacking
PT-141compatible
Community intimacy pairing; different receptors, no known interaction, no trial of the pair. PT-141 raises blood pressure briefly, so the vasopressin-like effects of oxytocin at high doses are worth keeping in mind.
Selankcompatible
Both nasal, both used for social anxiety; no known interaction.
Kisspeptin-10compatible
A speculative libido pairing; kisspeptin triggers oxytocin release in rodents, so the overlap is more than cosmetic, but nothing has tested the combination.
MDMA and serotonergic drugscaution
MDMA releases oxytocin and part of its social effect runs through the same system; adding more on top is uncharted and raises the risk of water retention and low sodium.
Blood pressure medicationcaution
Oxytocin can cause transient blood pressure swings in either direction, especially at higher doses or by injection.
Desmopressin and heavy fluid intakecaution
Oxytocin has antidiuretic activity at higher doses; combined with desmopressin or drinking large volumes it can lower sodium dangerously.
Pregnancyavoid
Oxytocin causes uterine contractions; outside hospital care it has no place in pregnancy by any route.
A community intimacy pairing: PT-141 drives desire through melanocortin receptors while oxytocin is added for closeness and orgasm intensity. No study has tested the combination.
Both are used intranasally for social anxiety, with selank for general anxiolysis and oxytocin for social ease. Untested together.
Kisspeptin has been shown to shape sexual and emotional brain responses in small imaging studies and appears in some libido protocols alongside oxytocin; a speculative pairing.
Safety
- ▲Nasal irritation, runny nose or sneezing after a spray
- ▲Headache
- ▲Flushing or a feeling of warmth
- ▲Mild nausea
- ▲Drowsiness or an emotional, weepy feeling in some people
- ▲Transient blood pressure changes, more relevant to injection
- ▲Injectable oxytocin is a hospital drug that causes uterine contractions and can cause dangerous blood pressure and heart rhythm changes. It should never be self injected for social or sexual purposes.
- ▲Pregnant women should not use oxytocin in any form outside clinical care; it can start contractions.
- ▲At higher doses oxytocin acts like vasopressin and causes water retention; combined with heavy fluid intake this can drop sodium to dangerous levels.
- ▲The nasal research is small and mixed. The best trials, in autism and sexual dysfunction, found no benefit over placebo.
- ▲Oxytocin effects are not simply positive. Some studies found it increased envy, in-group favoritism or distress in people with difficult relationship histories.
- ▲Nasal sprays mixed from research powder have no sterility or potency control, and oxytocin degrades quickly once in solution.
- ■Headache with confusion, nausea or vomiting, which can signal low sodium from water retention
- ■Palpitations, chest discomfort or fainting
- ■Any uterine cramping or bleeding in a woman who could be pregnant
- ■Signs of an allergic reaction such as hives, swelling or trouble breathing
- ■Worsening anxiety, irritability or low mood, which some studies have linked to oxytocin in vulnerable people
Community poll
Self-reported by visitors. Not clinical evidence.Oxytocin: frequently asked
What oxytocin dosage do nasal spray trials use?
Most research trials used 24 IU per dose intranasally, usually as three or four sprays split between nostrils, given 30 to 45 minutes before testing or once to twice daily in longer studies. A few used 16 or 40 IU. Community use reports 10 to 40 IU per dose. Higher is not better; some trials found smaller effects at larger doses.
Does nasal oxytocin actually reach the brain?
Probably some does, but less than early claims suggested. Nasal delivery raises oxytocin in cerebrospinal fluid in animal studies and alters brain activity in human imaging, so something gets through. How much reaches the regions that matter, and whether the behavioral effects come from the brain or from peripheral effects, is still debated.
Does oxytocin improve libido or sex?
The controlled evidence says not much. A crossover trial in healthy couples found no significant change in desire or arousal scores with intranasal oxytocin before sex, although some participants reported more intense orgasm. A trial in women with sexual dysfunction found placebo worked as well as oxytocin. The large placebo effect in these studies is itself worth knowing about.
Is Pitocin the same as the oxytocin sold online?
Chemically yes, the same nine amino acid peptide. Pitocin is a sterile, regulated injectable made for obstetric use under monitoring. Research vendors sell powder or premixed sprays of unknown purity and potency for intranasal use. The injectable form has no safe role outside a hospital, and the approved product's safety record does not carry over to a mixed at home spray.
References
- Intranasal oxytocin in children and adolescents with autism spectrum disorder. New England Journal of Medicine, 2021
- Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples. Hormones and Behavior, 2014
- Oxytocin increases trust in humans. Nature, 2005
- Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Frontiers in Neuroendocrinology, 2009
- Pitocin (oxytocin injection, USP) prescribing information. Par Pharmaceutical, 2020